study on Electroconvulsive Therapy among patients with schizophrenia.

Not Applicable

• Conditions: Health Condition 1: F20- SchizophreniaHealth Condition 2: F20-F29- Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders

• Registration Number: CTRI/2020/10/028562
• Lead Sponsor: Dr Muhammed Irfan PP

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

a)Patients fulfilling the ICD-10 criteria for Schizophrenia who are prescribed ECT by treating psychiatrist.

b)Patients going to receive a course of electroconvulsive therapy as advised by treating team.

c)Patient or Nominated representative of the patient giving informed consent both for ECT and for this study.

Exclusion Criteria

a)Substance use disorder in dependence pattern except caffeine and nicotine .

b)Patients diagnosed as suffering from major medical or neurological disorder by history or examination or investigation.

c)Those patients who received electroconvulsive therapy in previous 6 months.

d)Patients with intellectual disability disorder and other comorbid psychiatric illness.

e)Catatonia patients

f)Patients not amenable for baseline cognitive assessment

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical Response after ECTTimepoint: after 6 ECT session

Secondary Outcome Measures

Name	Time	Method
cognitive adverse effects of bifrontal and bitemporal ECT.Timepoint: after 6 ECTSession.